Colgate on acquisitions
This article was originally published in The Tan Sheet
Colgate-Palmolive would "not easily move into" OTC or pharmaceutical categories, CEO Reuben Mark stated during the Sanford Bernstein Strategic Decisions Conference June 1. Colgate has been identified as a potential bidder for Pfizer's Consumer Healthcare unit, which includes the Listerine oral care brand (1"The Tan Sheet" May 29, 2006, p. 6). Pfizer has expressed that it is not interested in selling its brands individually. Separately, Mark noted the firm's advertising spend will be up a record 13%-14% for the full year. Colgate put $297.1 mil. behind its global brands in the first quarter (2"The Tan Sheet" May 15, 2006, p. 11). The company also spent a record amount on advertising last year, with spending up 11.5%, according to the exec...
You may also be interested in...
While Pfizer considers whether to sell its Consumer Healthcare unit or spin it off to shareholders, potential buyers are placing bids with an eye toward an early June deadline
Colgate will launch new advertisements for Colgate Total toothpaste to respond to direct competition from Procter & Gamble's new Crest Pro-Health toothpaste, according to Colgate-Palmolive President and COO Ian Cook
Senior executives from Bayer outlined at a recent summit the contours of digital transformation already underway and the vital components of a successful digital team. Firms need to be able to operate technology at the “speed of business” and not “at the speed of a ticketing queue.”